DNAprint Genomics (DNAG)

[frogdreaming]

Blue, Excellent analysis. Well reasoned and dispassionate.

I have two questions, if you don't mind.

First, you state that;

Share dilution with the Dutchess Agreement will provide DNAP with 35 million.

Could you please elaborate? my concern lies with the current market cap. As there does not appear to be any significant change in the status quo on the short term horizon, it seems to be a fairly large inconsistency to expect to extract $35 million via a dilutive process from a company valued at less than half that amount.

Second, You follow on with;

So it is likely that any push for a r/s is for greater returns for share dilution. As of right now I probably will not be voting for a r/s.

Given that the Dutchess $35 Million Agreement will require sufficient shares to support it, and realizing that under the present share structure there are less than 500 Million available shares, most of them already committed to LaJolla, how do you envision the completion of the Dutchess Agreement without a R/S?
As a reference, IF all of the current 500 Million shares were available, it would still require a pps of .14 to complete the deal.

I look forward to your response.

regards,
frog